| |
| |
|
| Insider
Information: |
Ek John Frederick |
| Relationship: |
CFO |
| City: |
Carlsbad |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
180,728 |
|
|
Indirect Shares
|
20,000 |
|
|
| Direct
Value |
$524,111 |
|
|
|
Indirect Value
|
$58,000 |
|
|
| Total
Shares |
200,728 |
|
|
| Total
Value |
$582,111 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
8
|
|
Stock
price went up :
|
1
|
8
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
8.0
|
| Percentage
Gain/Loss : |
 5.5%
|
1,117.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Genmark Diagnostics, Inc. |
GNMK |
Chief Financial Officer |
2021-04-22 |
0 |
2019-02-18 |
0 |
Premium* |
|
|
Akoya Biosciences, Inc. |
AKYA |
CFO |
2024-04-01 |
180,728 |
2024-04-01 |
20,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
36 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GNMK |
Genmark Diagnostics, Inc. |
Chief Financial OfficerOfficer |
• – – |
2019-02-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
108,663 |
|
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
Chief Financial Officer |
• – – |
2019-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
184,258 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
Chief Financial Officer |
• – – |
2020-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
105,000 |
270,405 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
Chief Financial Officer |
• – – |
2021-01-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
50,449 |
228,733 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
Chief Financial Officer |
• – – |
2021-02-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,622) |
208,636 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
Chief Financial Officer |
• – – |
2021-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
45,000 |
253,636 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
Chief Financial Officer |
• – – |
2021-02-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(487) |
253,149 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
Chief Financial Officer |
• – – |
2021-02-23 |
4 |
D |
$0.00 |
$0 |
D/D |
(908) |
252,241 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
Chief Financial Officer |
• – – |
2021-02-25 |
4 |
D |
$0.00 |
$0 |
D/D |
(19,248) |
232,993 |
0 |
- |
|
| AKYA |
Akoya Biosciences, Inc. |
CFO |
• – – |
2023-03-20 |
4 |
A |
$0.00 |
$0 |
D/D |
160,000 |
160,000 |
0 |
- |
|
| AKYA |
Akoya Biosciences, Inc. |
CFO |
• – – |
2024-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
195,000 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
Chief Financial Officer |
• – – |
2020-02-25 |
4 |
S |
$3.81 |
$1,966 |
D/D |
(516) |
269,889 |
0 |
% |
|
| GNMK |
Genmark Diagnostics, Inc. |
Chief Financial Officer |
• – – |
2019-08-20 |
4 |
S |
$6.25 |
$3,188 |
D/D |
(510) |
174,138 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
Chief Financial Officer |
• – – |
2019-05-21 |
4 |
S |
$6.83 |
$3,381 |
D/D |
(495) |
177,963 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
Chief Financial Officer |
• – – |
2019-05-23 |
4 |
S |
$6.85 |
$3,432 |
D/D |
(501) |
177,462 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
Chief Financial Officer |
• – – |
2020-02-27 |
4 |
S |
$3.51 |
$3,650 |
D/D |
(1,040) |
268,849 |
0 |
% |
|
| GNMK |
Genmark Diagnostics, Inc. |
Chief Financial Officer |
• – – |
2019-02-20 |
4 |
S |
$6.16 |
$3,665 |
D/D |
(595) |
183,663 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
Chief Financial Officer |
• – – |
2019-05-30 |
4 |
S |
$6.60 |
$6,098 |
D/D |
(924) |
176,538 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
Chief Financial Officer |
• – – |
2019-11-25 |
4 |
S |
$5.43 |
$7,711 |
D/D |
(1,420) |
170,790 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
Chief Financial Officer |
• – – |
2019-08-27 |
4 |
S |
$6.03 |
$8,677 |
D/D |
(1,439) |
172,699 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
Chief Financial Officer |
• – – |
2019-08-05 |
4 |
S |
$5.87 |
$11,094 |
D/D |
(1,890) |
174,648 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
Chief Financial Officer |
• – – |
2020-05-28 |
4 |
S |
$9.52 |
$13,899 |
D/D |
(1,460) |
265,741 |
0 |
% |
|
| GNMK |
Genmark Diagnostics, Inc. |
Chief Financial Officer |
• – – |
2020-05-19 |
4 |
S |
$10.46 |
$17,238 |
D/D |
(1,648) |
267,201 |
0 |
% |
|
| GNMK |
Genmark Diagnostics, Inc. |
Chief Financial Officer |
• – – |
2020-11-24 |
4 |
S |
$13.17 |
$18,675 |
D/D |
(1,418) |
178,284 |
0 |
% |
|
| GNMK |
Genmark Diagnostics, Inc. |
Chief Financial Officer |
• – – |
2020-11-19 |
4 |
S |
$13.85 |
$22,672 |
D/D |
(1,637) |
179,702 |
0 |
% |
|
36 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
